Tuesday, 10 April 2012

Injectable Contraceptives-Breast Cancer Screening-Breast Cancer Risk-Fda Advisory Panel

FDA to weigh ultrasound screening tool for women with dense breasts

An FDA Advisory Panel is scheduled to decide whether to recommend approval of a new breast cancer screening indication for somo•v Automated Breast Ultrasound (ABUS) System on April 11. If approved by the FDA, somo•v would be approved for use as an adjunct to mammography for women with dense breasts. (Source: Health Imaging News) read more..

Injectable Contraceptives May Increase Breast Cancer Risk In Younger Women

The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that recent use of a year or more doubles the risk. The results of the study, led by breast cancer epidemiologist Christopher I. Li, M.D., Ph.D... read more..

Some Cancer Diagnoses Kill Quicker Than The Cancer

greenmedinfo.com April 10, 2012 A cancer diagnosis may be the most traumatic thing that can befall a patient within the contemporary medical system; that is, beyond the conventional cancer ... read more..

No comments:

Post a Comment